April 22, 2009 (FinancialWire) — Pharmaceutical Product Development, Inc. (NASDAQ: PPDI) said it has completed the acquisition of AbC.R.O., Inc., a contract research organization operating in Central and Eastern Europe.

The company said that the acquisition strengthens PPD’s ability to provide a range of clinical trial management and monitoring, patient recruitment, site identification and regulatory affairs services to its growing client base in the Balkans and surrounding countries.

PPD said that more than 230 employees have joined the firm with the acquisition, including co-founder and CEO Dana Leff, and co-founder and chairman Christa Pleasants.

AbCRO marks PPD’s second acquisition in Central and Eastern Europe. PPD acquired InnoPharm, an independent contract research organization based in Smolensk, Russia, last year.

Wilmington, North Carolina-based Pharmaceutical Product Development is a contract research organization providing discovery, development and post-approval services as well as compound partnering programs. The company’s clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations.

PPD has offices in 38 countries and around 10,500 employees.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.